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We have previously found that passively administered  antiserum  can simul- 
taneously suppress and enhance the immune response against different determi- 
nants of the same antigen molecule (1). This observation was made while study- 
ing the regulation of the immune response of rabbits to guinea pig ~/2-immuno- 
globulin;  passively  administered  anti-F(ab~)2  antiserum  suppressed  the  re- 
sponse  to  the  F(ab')2  region  of  the  antigen  molecule,  while  concomitantly 
augmenting antibody formation against the Fc region. 
In the present studies we have attempted to clarify the mechanisms of these 
contrasting phenomena. In particular we wanted to determine: (a) Whether the 
observed intramolecular  regulatory effects of passively administered  antibody 
might be peculiar to the antigen and antisera used. The results which we now 
report,  using  a  second  and  distinct  antigen-antibody  system  with  human 
secretory immunoglobulin A  (IgA) as antigen,  are remarkably parallel  to the 
previous  findings,  thereby  supporting  the  concept  that  these  intramolecular 
regulatory  effects may be  of general  occurrence  in the  immune  response.  (b) 
Whether the mechanisms  of suppression  and  enhancement  are directly  inter- 
related.  Although it has not been possible  to answer this  question unambigu- 
ously, our findings support the idea that they are independent phenomena. 
Materials and Methods 
Proteins.- 
Serum IgA: Human IgA myeloma protein Cat ('yAI, K) was isolated from ascitic fluid by 
starch block electrophoresis (2). 
Secretory IgA : Lyophilized pooled human colostrum was restored to the original volume by 
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the addition of distilled water. The isolation procedure for the secretory IgA was essentially 
that of Cebra and Robbins (3). The colostrum was centrifuged at 4000 rpm for 10 min, after 
which the lipid at the surface was removed and the underlying liquid was centrifuged at 30,000 
rpm (# 30 rotor) in a Spinco L2-65 ultracentrifuge for 2  hr at 4°C.  The milky  top portion 
was removed and the remaining liquid was brought to pH 4.6 by the addition of 1 N acetic 
acid to precipitate residual casein. The preparation was then dialyzed against 0.01 M sodium 
phosphate, pH  7.0,  and passed with the same buffer through a  column of DEAE-cellulose 
(100-200 ml of packed DEAE-cellulose per 100 ml of colostrum) previously equilibrated with 
the same buffer. When the optical density of the effluent had returned to the baseline, the 
above buffer plus 0.1 u  NaC1. was passed through the column, and the protein subsequently 
eluted  was passed  through  Sephadex G-200  in  0.15 ~  NaC1. The void  volume  contained 
secretory IgA; it was determined to be pure by immunoelectrophoresis  at 10 mg/ml with two 
different rabbit antisera against whole colostrum, and had an $20. ~ =  10.6 at a concentration 
of 0.6 mg/ml (ultraviolet optics). The purity of the secretory IgA preparation was also con- 
firmed by the observation that when it was labeled with 12~I, it was 100% precipitable by an 
antiserum specific for the secretory component. From 5-10 mg of pure secretory IgA were 
obtained per milliliter of original colostrum. 
Guinea pig T2~mmunoglobulin:  Purchased from Pentex, Inc., Kankakee, IlL,  and further 
purified by passage through DEAE-cellulose (4). 
Guinea pig F(ab')2 fragments:  F(ab')2 fragments of purified guinea pig 3,2-immunoglobulin 
were prepared by pepsin digestion (5). Their purity was confirmed by double diffusion in agar 
gel with a rabbit anti-')'e-immunoglobulin  antiserum where a reaction of partial identity with 
intact 3'2-immunoglobulin  molecules was obtained. 
Chicken ovalbumln: Crystallized chicken ovalbumin was obtained from Pentex, Inc. 
Rabbits.~Randomly  bred rabbits, weighing 2-2.5 kg,  were obtained from Bristol Rabbit 
Farms, Nassau, N.Y. 
A ntisera.-- 
Antiserum vs. serum IgA:  Rabbits were each immunized intramuscularly in several sites 
with a total of 2 mg of IgA myeloma protein emulsified in complete Freund's adjuvant (Difco 
Laboratories, Detroit, Mich.). They were bled several times between 4  and 8 wk after im- 
munization and the sera from various bleedings were pooled. By double diffusion in agar gel 
the antiserum gave a reaction of identity between the IgA mye]oma protein and secretory IgA. 
Hereafter, this antiserum will be referred to as "anti-serum IgA antiserum." Separate pools of 
such antisera, prepared from different groups of rabbits, were used in each of the two experi- 
ments performed. 
Antiserum  vs.  guinea  pig F(ab')2 fragments:  Anti-F(aW)2 antiserum was obtained from 
rabbits which had been immunized in the footpads with 0.5 or 1.0 mg of the F (ab')2 fragments 
of guinea pig 3'2-immunoglobulin  incorporated in complete Freund's adjuvant.  By double 
diffusion  in agar gel these antisera gave reactions of identity between F(ab')2  fragments and 
whole T2-immunoglobulin  molecules. A different pool of antisera from different bleedings and/ 
or rabbits was used in each of tile three experiments performed. 
Purified  rabbit qtG-immunoglobulln from  anti-guinea  pig F(ab')2  antiserum:  The  "yG-im- 
munoglobulin of rabbit anti-F(ab% antiserum was separated either by direct passage of the 
serum (dialyzed against 0.02 M sodium phosphate buffer, pH 7.7) through a column of DEAE- 
cellulose  equilibrated with the same buffer, or by passage after initial precipitation at 4°C 
with one-third saturated (NH 4)2SO 4 (6). The eluted 3~G-immunoglobulin was dialyzed against 
0.15 ~t NaC1 and then concentrated by ultrafiltration. In one experiment the concentrated 
preparation was passed through a  column of Sephadex G-200  equilibrated with 0.1 M tris 
(hydroxymethyl)aminomethane (Tris)-HC1 buffer, pH 8.0, containing 0.5 ~  NaC1, and in this 
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at 280 rim. By immunoelectrophoresis  at a concentration of 6 mg/ml, with two different sheep 
antisera against rabbit 3'M-immunoglobulin, the 3'G preparation contained no 3'M-immuno- 
globulin. Finally, normal rabbit serum was added to give a final concentration of about 10% 
serum (v/v), and the preparation was stored at --15°C until use. 
F(ab')2 fragments  of rabbit 7G4mmunoglobulin vs. guinea pig F(ab')2 fragments:  These were 
prepared by pepsin digestion (5) and purified by passage through a column of Sephadex G-200 
equilibrated with 0.1 M Tris-HC1  buffer, pH 8.0, containing 0.5 M NaC1. The absence of any 
intact 3'G molecules in the F(ab')~. preparation was confirmed by double diffusion in agar gel 
with several sheep and goat antisera specific for the Fab and Fc regions of rabbit 3"G-immuno- 
globulin. 
Antiserum  vs. complete  Freund's  adjuvant:  Several rabbits were injected with 2 ml  of an 
emulsion of equal volumes of saline and complete Freund's adjuvant (CFA) 1 divided among 
the four footpads. 6 wk later the animals were bled and their sera were pooled. 
Normal rabbit serum  (NRS): Obtained from Pel-Freez Biologicals,  Inc., Rogers, Ark. 
Immunization  of Experimental  Rabbits.--Rabbits  used in the different experiments were 
immunized with antigens incorporated in CFA. Each animal received 0.5 mg of guinea pig 3'2- 
immunoglobulin or human secretory IgA, or 1 mg of ovalbumin, in a 2 ml emulsion distributed 
among the four footpads. 
Administration  of Antiserum  to  Rabbits.--In  all  experiments antiserum was injected at 
several intervals into the marginal vein of the ear. Control groups received comparable volumes 
of normal rabbit serum or irrelevant immune serum. 
In the two studies in which secretory IgA was used for active immunization, the anti-serum 
IgA antiserum was not diluted before injection, and a total of about 60 mg of antibody was 
administered per rabbit. 
In the study of the effect of different doses of anti-guinea pig F(abr)2  antiserum on the 
response to guinea pig 3"2-immunoglobulin,  three different dilutions of the anti-F(ab')~ anti- 
serum pool were prepared with NRS. The original  pool (containing 2.6 mg of antibody per 
milliliter) and the three additional dilutions had successive fivefold  differences in their con- 
centrations of anti-F(ab')2 antibody. Four groups of rabbits were injected intravenously at 
several intervals with equal volumes of the respective serum dilution, so that each rabbit in a 
given group received a total of 60, 12, 2.4, or 0.48 mg of anti-F(ab')  2 antibody. 
In the remaining two experiments the original preparations of whole anti-guinea pig F(ab')2 
antiserum, the derived 3,G-immunoglobulin,  or the F(abt)z fragments of the 3"G-immuno- 
globulin were diluted to the desired concentration with saline and NRS to yield solutions of 
comparable total protein content. The effects of 3 or 12 mg of whole antibody molecules,  and 
of 20 mg of antibody F(abt)2 fragments were explored. 
Radioiodination  of Proteins.--Purified human secretory IgA, guinea pig 3"2-immunoglobulin, 
and  the F(ab~)2 fragments of 3/2-immunoglobulin  were iodinated with  125I (New  England 
Nuclear Corp., Boston, Mass.) according to the iodine monochloride technique (7). 
Antibody Determinations.--Quantitative  precipitation tests (8) were performed to determine 
the antibody content of rabbit sera obtained at various times after immunization. The anti- 
sera were mixed with the corresponding radioiodinated antigens, and the amount of antigen 
precipitated in each tube was calculated from its known specific activity. Immune precipitates 
were dissolved in 0.02 M sodium dodecyl sulfate and their optical densities  were read at 280 nm. 
In the experiments in which secretory IgA was used as antigen, the total amount of anti- 
secretory IgA antibody present was directly measured by  quantitative precipitation with 
purified secretory IgA. The amount of antibody produced against the secretory component 
1 Abbreviations  used in this paper: CFA, complete Freund's adjuvant; NRS, normal rabbit 
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portion of the molecule was determined as follows: First, the antisera were absorbed with 
normal human serum (three volumes normal human serum:five volumes antiserum)  to remove 
antibodies against c~ and L chains.  (The effectiveness of this absorption was confirmed by the 
absence of a precipitation line between  the absorbed sera and normal human serum during 
double diffusion in agar gel.) The amount of antibody against secretory IgA which remained 
after absorption (i.e., antibody specific for the secretory component) was determined by quanti- 
tative precipitation with secretory IgA.  2 Finally, the content of anti-serum IgA antibody in 
each  sample was considered  to be the difference between  the measured  amounts of anti- 
secretory IgA antibody and anti-secretory component  antibody. 
In the experiments in which guinea pig ~'2-immunoglobulin was used as antigen, the amounts 
of anti-~/2-immunoglobulin and anti-F  (ab')2 fragment antibodies in each serum were measured 
by quantitative precipitation with the corresponding radioiodinated antigens, The amount of 
anti-Fc antibody in each sample was considered to be the difference between the two. 
The antibody response of rabbits immunized with ovalbumin was determined by quantita- 
tive precipitation with unlabeled ovalbumin. 
RESULTS 
Augmentation of the Immune Response  to the Secretory Component  of Secretory 
IgA  by the Passive Administration of Antiserum against Serum IgA 
The  secretory  IgA molecule  contains  distinct  immunologically and  chem- 
ically defined regions, a  and L  chains like those in serum IgA, plus an additional 
moiety, the  secretory component,  which  is not  present in serum  IgA or any 
other serum protein (11). In our experience, when secretory IgA is used as an 
antigen,  most  of  the  precipitating  antibody  elicited  is  directed  against  the 
region comparable to serum IgA, i.e. ~  and L  chains, rather than  against the 
secretory component. In fact we have been unable to induce good precipitating 
antisera against the secretory component  of secretory IgA with conventional 
immunization schemes (see also reference 12). For these reasons, secretory IgA 
appeared  to  represent  an  analogous  yet  independent  system  with  which  we 
might  confirm  and  extend  our previous findings with  guinea pig ~,2-bnmuno- 
globulin. In the present studies we attempted to enhance the immune response 
against the weakly immunogenic determinants of the secretory component by 
administering  antiserum  specific  for  serum  IgA  to  rabbits  immunized  with 
secretory IgA. The results of two such experiments are presented in Table I. 
Two principal points which emerge from the data are: (a) In both studies the 
production  of  antibody  specific for  the  secretory  component  is  significantly 
enhanced  (more  than  twice  as  great)  in  the  experimental  rabbits  receiving 
anti-serum  IgA  antibody  in  comparison  with  the  control  rabbits.  (b)  The 
enhancing and  suppressive effects of passively administered antibody are not 
parallel in  time;  augmentation  becomes  evident later than  does  suppression. 
Normal human serum has recently been reported to contain from 5 (9) to 35 (10) ~g/ml 
of secretory IgA. Thus, small amounts of anti-secretory component antibody may be removed 
during the absorption procedure.  However,  the levels of anti-secretory component  antibody 
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Thus, by 16 days suppression of the response toward determinants in common 
with  serum IgA is  already marked,  but there  is  not yet  an  increase in the 
level of anti-secretory component antibody. The same effect is also evident in 
the experiments below. 
TABLE I 
Antibody Produced after Active  Immunization with Secretory IgA by Rabbits Receiving 
A nti-Serum IgA Antiserum Passively 
Days after  Rabbits*  Exp. No.  immunization 
Mean antibody levels (OD at 280 nm/ml 
antiserum) 
Anti-serum IgA  Anti-secretory 
(±SEM)  component (±SEE) 
16  Experimental  0.54  0.49 
Control  2.50  0.54 
23  Experimental  1.15  1.73 
Control  4.63  0.70 
29  Experimental  3.53  4-  0.93  1.31  4-  0.28§ 
Control  4.17  ±  0.49  0.49  ±  0.03§ 
35  Experimental  3.22  1.29 
Control  4.73  0.53 
* A different pool of antiserum was used in each experiment. In experiment 1, five experi- 
mental rabbits each received a total of 57 mg of anti-serum IgA antibody distributed in the 
following proportions: 28% (on the day preceding active immunization), 28%  (day 1 after 
immunization), 19% (days 3 and 7), and 6% (day 10). In experiment 2, four experimental 
rabbits each received a total of 60 mg of anti-serum IgA antibody distributed in the following 
proportions:  25%  (day preceding immunization),  25%  (day  1 after  immunization),  17% 
(days 4, 8, and 20). Control rabbits (five in each experiment) received comparable volumes of 
NRS. 
:~ Where SE~t is not given in the table,  this indicates that titrations were performed on 
t)ools obtained by mixing equal volumes of serum from the animals in each group. In our 
experience, such determinations approximate very closely the arithmetic means determined 
by titration of the individual sera from each group. 
§ The difference between these means is statistically significant at the I% level (Student's 
t test). 
Augmentation of the Immune Response  to the Fc Region of Guinea Pig 
"r2-Immunoglobulin  by Passive Anti-F(ab')2 Antiserum 
Relationship  between the Suppressive and Enhancing Effects  of Antiserum.- 
In order to determine whether the augmentation of the  immune response to 
certain determinants on a molecule is dependent upon the suppression of anti- 
body formation against other determinants on the same molecule, we adminis- 
tered  varying doses  of  rabbit anti-F(abP)2 antiserum to  rabbits actively im- 
munized  with  whole  guinea  pig  ~2-immunoglobulin, and  observed  whether ANTI-F(ab')  2 RESPONSE 
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FIG.  1.  Regression lines relating the amounts  of anti-F(ab')2 and  anti-Fc  antibody pro- 
duced to the dose of passively administered anti-F (ab  ~) 2 antibody (semilogarithmic plot). 
Antibody content  (arithmetic means)  at  day  35  after immunization was determined by 
titration of sera of individual rabbits; these group means are indicated by solid dots. The 95% 
confidence interval for each regression line is delineated by dotted lines. 
Mean antibody levels (OD/ml serum) in the control group receiving normal rabbit serum 
were  1.2  (anti-F[ab'J2)  and  1.5  (anti-Fc).  Anti-Fc antibody production by groups receiving 
60,  12, or 2.4 mg of antibody was significantly enhanced in relation to the control group (P  < 
0.01,  <0.05,  <0.05, respectively; Student's t test). Anti-F(ab~)2 antibody synthesis by groups 
receiving 60 or 12 mg of antibody was significantly suppressed in relation to the control group 
(P  <  0.001; 0.05  <  P  <  0.10, respectively). For experimental details see legend to Fig. 2. 
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enhancement  of  the  immune  response  to  the  Fc  region  could  be  obtained 
with doses of antibody which did not cause discernible suppression of antibody 
synthesis against the homologous region (Figs. 1 and 2). 
The antibody content of the sera of individual rabbits at 35 days after im- 
munization  was  used  to  plot  regression lines  relating  the  amounts  of  anti- 
F(ab')2 and anti-Fc antibody produced to the logarithm of the dose of anti- 
F(ab')2 antibody administered (Fig. 1). Analysis of variance indicates that the 
linear regression obtained with regard to the amount of anti-F(ab')2 antibody 
produced by the different groups is statistically significant (P <  0.01), as is the 
FIG. 2. Antibody produced after active immunization  with guinea pig 3'2-immunoglobulin 
by rabbits receiving  different amounts of passive anti-F(ab')~ antibody. 
Each group (of six rabbits) received the following  volumes of its respective dilution of 
anti-F(ab')2 antiserum per animal (see  Materials and Methods): 7 ml (i day preceding  active 
immunization), 7 ml (day 3 after immunization), 7 ml (day 7), and 2 ml (day 12). A control 
group (of eight rabbits) received  normal rabbit serum instead. Titrations were performed on 
pools obtained by mixing equal volumes  of serum from the animals in each group. 
linear  regression  obtained  for the  amount  of  anti-Fc  antibody  synthesized 
(P<  0.05).  In both cases, the deviations from regression are not significant. 
Thus, there is a relation between the amount of anti-F(abt)2 antibody passively 
administered and the degree of (a) suppression of anti-F(ab')~ antibody syn- 
thesis and (b)  enhancement of anti-Fc antibody synthesis. 
However, evaluation of these data in relation to mean antibody production 
by  control  rabbits  receiving normal  rabbit  serum  (see  legend,  Fig.  1;  also 
Fig. 2) indicates that the enhancement observed is not directly dependent upon 
the  suppression  of the  response to  determinants  of the  F(ab')2  region.  The 
higher doses of passive antibody (60,  12 rag) caused suppression of anti-F(ab')2 
antibody production  and  also  enhancement  of  anti-Fc  antibody formation. 
A  smaller dose (2.4 rag)  of passive anti-F(ab')2  antibody could also increase 
anti-Fc antibody formation. For example, at day 35 the enhancement caused 994  REGULATION OF  THE  IMMUNE RESPONSE 
by 2.4,  but not 0.48  mg,  was  significant at the  5 %  level (Student's t  test). 
Interestingly, however, the 2.4 rng dose did not suppress anti-F(ab')2 antibody 
production but instead appeared  to  augment it  as  well as  anti-Fc antibody 
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FIG. 3.  Anti-F(ab')2 antibody produced after active immunization with guinea pig 3'2-im- 
munoglobulin by rabbits receiving passive anti-F(ab')2 antibody in different forms. 
In experiment 1 (upper half) two groups of rabbits received a total of 3 mg of antibody per 
animal in either whole anti-F(ab% antiserum or purified "yG-immunoglobulin,  distributed  in 
the following  proportions: 30% (1 day preceding active immunization), 30%  (day 3 after im- 
munization), 30% (day 7), and 10% (day 12). The control group received comparable volumes 
of NRS. Rabbits receiving rabbit F(ab% fragments specific for guinea pig F(ab02 were each 
injected with a total of 20 mg of antibody fragments administered by eight daily injections 
beginning on the day of immunization. All groups consisted of five rabbits. 
In experiment 2 (lower half) two groups of rabbits received a total of 12 mg of antibody 
per animal in either whole anti-F(ab')2 antiserum or purified "yG-immunoglobulin,  adminis- 
tered as in experiment 1. The rabbits receiving anti-CFA antiserum or NRS were injected with 
comparable volumes. The groups contained the following  numbers of rabbits: whole antiserum, 
five; 3~G antibody, five;  anti-CFA, five; NRS, seven. 
In all cases titrations were performed on pools obtained by mixing equal volumes of serum 
from the animals in each group. 
formation. Because of the great variation in the amount of antibody produced 
by individual  rabbits, this apparent increase in anti-F(ab')2  antibody production 
was not statistically significant at the 5 %  level (for  the  group receiving 2.4 
nag, 0.05  <  P  <  0.10, at day 35). 
Nonetheless, an  important point which  emerges from  the  group  receiving 
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enhancement of the anti-Fc antibody response can occur without concomitant 
suppression  of  anti-F(ab')~  antibody  synthesis.  Furthermore,  the  levels  of 
anti-F(ab')~ and anti-Fc antibody at different times after immunization (Fig. 2) 
indicate  that  the  suppressive  effect  occurs  early  in  the  immune  response, 
whereas enhancement is evident only at a later time. 
Ability of "yG Antibody or Fragments Specific for Guinea Pig F(ab')2  to En- 
hance the Anti-Fc Response.--In view of contradictory reports attributing the 
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FIG. 4. Anti-Fc antibody produced after active immunization  with guinea  pig 3'2-immuno- 
globulin by rabbits receiving passive anti-F(ab')2 antibody in different forms. For experi- 
mental details see legend to Fig. 3. 
enhancing effect of antiserum to only the "yM class of antibody (13), or to both 
the I'M and 7G  classes  (14,  15),  experiments were performed to investigate 
the ability of the ~G fraction of rabbit anti-guinea pig F(ab')2 antiserum to 
enhance the immune response against the Fc region of guinea pig "y2-immuno- 
globulin. In addition, to determine whether the enhancing effect is dependent 
upon the Fc portion of the antibody molecule, the ability of the F(ab')2 frag- 
ments of the ~G antibody to enhance anti-Fc  antibody formation was  also 
explored. The composite data presented in Figs. 3 and 4 are the results of two 
experiments in which different doses of rabbit  anti-guinea pig  F(ab')2  anti- 
bodies,  or  their  pepsin  fragments,  were  used.  In  both  experiments  whole 
antiserum or the 3,G-immunoglobulin derived from it (containing equal amounts 
of anti-F[abq2  antibody) suppressed  anti-F(ab')~ antibody synthesis (Fig. 3) 996  REGULATION  OF  THE  IMMUNE  RESPONSE 
and enhanced the anti-Fc response (Fig. 4). As noted also in the previous ex- 
periments,  the  enhancement effect became evident  at a  later time after im- 
munization (day 36) than did suppression (day 16 or earlier). 
Interestingly,  the  F(ab')2  fragments  of the "rG  antibody also  caused  sup- 
pression of the anti-F(ab')2 response (in accord with the previous findings in 
references 16-19),  but did not show evidence of having caused  enhancement 
of anti-Fc antibody synthesis at any of the times tested. In this instance,  a 
total of 20 mg of antibody fragments were injected by eight daily injections, 
to try to compensate for the short half-life of circulating rabbit F(ab')e frag- 
ments  (20). 
Specificity of the Enhancement Phenomenon 
Suppression has been shown to be specific at the antigenic determinant level 
(1,  14,  15,  21-25).  In contrast,  enhancement is  nonspecific in the sense that 
antibodies specific for one portion of a molecule can enhance the production of 
antibodies  directed  toward  another  portion;  for example,  anti-F(ab')2  anti- 
serum can enhance the production of antibodies against Fc determinants. But 
while nonspecific, this enhancement of the anti-Fc response most likely stems 
from the initial specific binding of anti-F(ab')2 antibody to the F(ab')~ region 
of the guinea  pig ~2-immunoglobulin molecule. However, an  alternative  ex- 
planation might be that these antisera enhance the immune response entirely 
nonspecifically, that is,  independently of their anti-F(ab')2 antibody content. 
This is unlikely for the following reasons: (a) Enhancement is mediated by the 
7G-globulin fraction of the antisera, as shown above. (b) We have previously 
shown that an anti-dinitrophenyl antiserum could not enhance the response of 
rabbits to the Fc region of guinea pig 3,2-immunoglobulin (1). In order to clarify 
further this point, two experiments were performed. 
(a)  Since the antigens used for immunizing both the donors and recipients 
of passive antisera were incorporated in CFA, we wanted to determine whether 
antibodies directed against components of CFA, or nonspecific serum constitu- 
ents, might be contributing to the enhancement observed in our experiments. 
For this purpose,  a  group of rabbits immunized with guinea pig 3,2-immuno- 
globulin  (experiment 2,  Figs.  3  and  4)  was  also  injected with pooled serum 
derived from rabbits previously immunized with CFA alone. As Figs. 3 and 4 
indicate,  this  antiserum  did  not cause  enhancement of the  response against 
the F(abP)~ or the Fc regions of 3,2-immunoglobulin. 
(b) In order to exclude the possibility that the enhancement effect is due to a 
nonspecific enhancing  factor in  the  passive  antisera  rather  than  to  specific 
antibody, the ability of antiserum specific for serum IgA to enhance the im- 
mune response against an unrelated antigen,  chicken ovalbumin,  was tested. 
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antiserum against serum IgA was not significantly different from the response 
of five control rabbits receiving ovalbumin and normal rabbit serum. 
DISCUSSION 
The present studies represent an attempt to clarify the mechanisms through 
which passively administered antibody may simultaneously enhance and sup- 
press the immune response against different antigenic determinants on the same 
molecule.  The  significant  new  observations  which  have  been  made  can  be 
summarized as follows: 
(a) Our previous findings with guinea pig ~2-immunoglobulin as antigen in 
rabbits  (1)  have been confirmed using  an analogous  but different system of 
antigen and antibodies. In the present studies, human secretory IgA was used 
as an antigen in rabbits which received passively serum from rabbits immunized 
with  human  serum  IgA.  A  significant  enhancement  of  antibody  synthesis 
against  the  secretory component portion  of the  secretory IgA molecule was 
achieved,  while  antibody  production  against  the  portion  common  to  both 
serum  and  secretory IgA,  i.e.  a  and  L  chain determinants,  was  reduced  in 
comparison with that of control animals. 
(b)  In  both  systems  used  (guinea  pig  ~2-immunoglobulin  +  anti-F[ab']2 
antibody, and human secretory IgA +  anti-serum IgA antibody), the timing 
for achieving maximum suppression  or enhancement of antibody production 
was  not the  same.  The suppressive effect was  first noted and most marked 
early  in  the  immune  response,  whereas  the  enhancement  phenomenon was 
evident only much later. This difference, which has not to our knowledge been 
pointed out before, may be one of the reasons for some conflicting results in the 
literature,  and  suggests  that  suppression  and  enhancement  may  be  inde- 
pendent phenomena. 
(c) Other findings also suggest that the mechanisms of the suppression and 
enhancement phenomena may be unrelated: (i) The fact that enhancement of 
of the anti-Fc antibody response could be obtained with doses of anti-F(ab')2 
antibody that  did  not  cause  suppression  of  anti-F(ab')2  antibody  synthesis 
suggests that enhancement of the response to certain determinants on a mole- 
cule  is  not  dependent upon  the  simultaneous  discernible suppression  of the 
response to other determinants on the same molecule. (ii)  While the F(ab')2 
fragments  of rabbit  antibody directed against  guinea  pig  F(ab')2  fragments 
could  still  mediate  suppression  of the  immune  response to  the  homologous 
antigenic determinants (see also 16-19), no enhancement effect toward the Fc 
region  of  the  guinea  pig  ~,2-immunoglobulin  molecule  was  observed.  These 
findings might be questioned on the basis of the higher catabolic rates of the 
antibody F(ab')2 fragments when injected into rabbits (20). It should be pointed 
out, however, that other results with the same antigen-antibody system (see 998  REGULATION  OF  TIlE  IMMUNE  RESPONSE 
Results,  Paragraph 5)  demonstrated that  enhancement can be obtained with 
smaller doses than those needed for suppression. Therefore, the higher catabolic 
rates of the F(ab')2 fragments, leading to their fast elimination,  should affect 
suppression more readily than enhancement,  yet this is the  opposite of what 
has been observed. Thus,  it seems reasonable to conclude that  enhancement, 
but  not  suppression,  is  Fc dependent.  It remains to  be determined  whether 
the  importance of the  Fc region for enhancement stems from its role in the 
concentration  of antigen  in strategic regions of the lymphoid organs  (26-28) 
or from some other unknown mechanism. 
(d)  In  view  of  previous  findings  on  the  relative  importance  of  different 
classes of antibodies for enhancement and suppression (13,  14,  29-33),  it is of 
interest  that  in  our  experiments the "~G fraction  of antisera  was  capable of 
mediating  both  effects.  Since  our  "rG preparations  contained  no  detectable 
~M-immunoglobulin,  these  results  appear  to  rule  out  the  possibility  of  an 
exclusive role for ~,M antibody in the enhancement phenomenon (see also 14). 
It still remains possible, however, that  on a molar basis ~,M-immunoglobulin 
may prove to be a more effective mediator of the augmentation of the immune 
response. 
(e)  Finally,  the possibility that  the  enhancement  effect observed after the 
passive administration  of antiserum is initiated  by a  serum factor other than 
antibody seems unlikely for the following reasons:  (i) It can be obtained with 
the DEAE-purified ~,G fraction of the antiserum. (ii)  It is not mediated by the 
serum of rabbits immunized with CFA alone. (iii)  We have previously shown 
that  an antiserum obtained from rabbits immunized with dinitrophenylated- 
bovine gamma globulin does not enhance the response of rabbits against the 
Fc fragment of guinea pig ~,~-immunoglobulin  (1);  and  (iv)  in this study we 
found that an antiserum specific for human serum IgA, capable of enhancing 
the  immune  response  to  the  secretory  component  of human  secretory  IgA, 
did not significantly enhance the response of rabbits to ovalbmnin. 
In  summary,  it  appears  that  our  findings  can  best  be  explained  by  the 
hypothesis  proposed  by  Pearlman  (14)  that  antibodies  suppress  specifically 
the immune response to determinants to which they can bind, and simultane- 
ously enhance the response to other determinants  on the same molecule in  a 
"nonspecific" manner. According to this view, the ability of an antiserum of 
heterogeneous specificity to cause discernible suppression or augmentation of 
the  response against  a  multideterminant  antigen  may actually represent the 
net  balance  of  these  two  effects at  the  determinant  level  (see  also  14,  34). 
With the exception of certain findings such as those of Henney and Ishizaka 
(35)  and of Cerottini et al.  (24),  which  are in contradiction with some of the 
data  presented  above,  many  other  observations  on  the  enhancing  effect  of 
passive antibody (14,  15,  25,  34)  agree with our findings.  Furthermore, many 
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munization to some (presumably stronger) determinants in the induction of an 
antibody response against other weakly immunogenic determinants on the same 
molecule  (36-41)  or  cell  (42,  43),  and  in  the  induction  of  transplantation 
immunity against adjacent weak cell surface antigens  (44-47).  Some of these 
effects  are  referred to as  "hapten-carrier  relationships"  or  "cooperation of 
antigenic determinants." 
From the recent studies of Mitchison et al.  (48-50), Rajewsky et al.  (51), 
Katz et al. (52), and Paul et al. (53), there has arisen the hypothesis that this 
effect is  mediated  by  the  interaction  of  carrier-specific and  hapten-specific 
cells.  Their findings suggest that cell-bound receptors rather than circulating 
anti-carrier antibodies play an important role in augmenting the response to 
haptenic determinants,  since in none of these studies could passively admin- 
istered anti-carrier antiserum substitute effectively for active immunization to 
the  carrier  (40,  51,  52)  or  adoptive  transfer  of  carrier-primed  lymphocytes 
(48,  53) in enhancing the anti-hapten response. 
Nonetheless,  what  may  appear  to  be  two  different mechanisms  for  aug- 
mentation of the immune response,  i.e.  augmentation induced by circulating 
antibody or by cell cooperation, may yet prove to be a reflection of the same 
immunologic phenomenon. It may be, for example, that the powerful enhancing 
effect of carrier-sensitized cells,  in comparison with the poor activity of serum 
antibodies, is due to the specific localization of the sensitized cells  in certain 
areas of the lymphoid organs where secreted antibody might be more effective. 
Alternatively it is possible that under certain circumstances cell-bound anti- 
body may be released into the circulation and cause the localization of antigen 
at the surface of other cells. There is a good precedent for this reasoning in the 
case of anaphylactic antibody, for it is well known that although it may be 
quite  easy to  sensitize  an  animal  for anaphylactic  shock  (and  in  this  case 
anaphylactic antibody, produced by lymphoid cells,  is  bound to mast  cells), 
it  is  much  more  difficult  to  demonstrate  circulating  reagin  (IgE).  In  any 
case,  whatever  its  mechanism,  our  results  demonstrate  that  intramolecular 
augmentation of the immune response can be used effectively toward the prac- 
tical goal of providing strong antisera against molecular determinants that are 
but weakly antigenic when immunization is carried out by more conventional 
schemes. 
SUMMARY 
The ability of passively administered antibody to suppress the immune re- 
sponse  against  homologous  antigenic  determinants  while  concomitantly en- 
hancing the response against other unrelated determinants of the same antigen 
molecule has  been established in two distinct antigen-antibody systems:  (a) 
guinea  pig  ~2-im~unoglobulin  +  passive  anti-F(ab')2  antibody,  where  sup- 
pression  of anti-F(ab')2  antibody synthesis  is  accompanied by enhancement 1000  REGULATION  OF  THE  IMMUNE  RESPONSE 
of the  anti-Fc  response;  and  (b)  hmnan  secretory IgA +  passive  anti-sertml 
IgA antibody,  where suppression  of antibody production against the a  and L 
chains  accompanies  augmentation  of  the  response  to  the  secretory  com- 
ponent. 
The mechanisms  of the suppressive  and  enhancing effects are probably un- 
related  for the following reasons:  (a)  Enhancement  of the response to certain 
determinants may be obtained without discernible suppression of the response 
to  the  homologous  determinants;  and  (b)  the  F(ab')2  fragments  of  passive 
antibody can mediate immune suppression  but were not observed to enhance 
the response against the unrelated determinants  of the same antigen molecule. 
Also, the timing for achieving maximum suppression  or enhancement  of anti- 
body formation  is  not  the  same;  enhancement  was  obtained  only at  a  later 
time. 
Both the enhancement and suppressive effects were obtained with the puri- 
fied "yG fraction  of  antisera.  This  finding  rules  out  an  exclusive  role  of yM 
antibody in the enhancement phenomenon. 
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